Symbotic

Symbotic increased revenue in Q3 by 22% to $721 million, adjusted EBITDA more than doubled to $95 million, and the company posted a GAAP net profit of $55 million after a loss a year earlier. The non-GAAP gross margin improved to 25% and software and service revenues grew significantly. Despite the strong results, the stock fell after hours as investors weighed the outlook, margin trajectory and timing of key growth drivers such as SymMicro and new warehouse configurations. For Q4, Symbotic expects revenue of $760–780 million and adjusted EBITDA of $100–105 million. » Więcej na de.investing.com

Symbotic reported Q2 revenue of $676.5 million, $77.8 million adjusted EBITDA and guided Q3 revenue of $700–720 million, while holding a contracted backlog of about $22.7 billion. Bears argue the market is pricing in flawless backlog conversion and margin stability, leaving little room for delays, customer concentration issues or deteriorating unit economics. With a high forward P/E (~92.6) and significant execution sensitivity, the thesis warns valuation could compress materially if deployment cadence or margins weaken. » Więcej na finance.yahoo.com

Symbotic reported 23% year‑over‑year revenue growth and a $9 million net income in Q2, but the small per‑share profit disappointed investors. Shares fell 21.4% in May and continued to slide after SoftBank sold 5.59 million shares, pressuring the stock. The company is expanding deployments (46 to 70 systems year‑over‑year), won a Medline healthcare contract and holds a $22.7 billion backlog, supporting a buy‑the‑dip thesis despite near‑term market reaction. » Więcej na finance.yahoo.com